IFI-B · Naringin Reduction Series

Specimen SS-F-BTR-539 // ZERO-BITTER · IFI-B

Naringin Reduc · T3 Biolistic-A

Citrus sinensis

Orange

Tier IIINaringin Reduction Series

Target Trait

60%

% reduction

Naringin reduction

Technical Specifications

SKU

SS-F-BTR-539

Genomic Edits

6

GC Content

44.9%

Construct Length

3,536 bp

Promoter System

UBI-1 / 35S CaMV

Expression System

Biolistic particle bombardment

Host Strain

Gold particle 0.6 µm

Receptor Target

TAS2R38 (suppression)

IFI Score

60

Pathway Edits

  • RhaT rhamnosyltransferase RNAi prevents final rhamnosylation of naringenin-7-glucoside to bitter naringin
  • GT1 glucosyltransferase alternative isoform redirects naringenin to non-bitter glycoside conjugates
  • CHS chalcone synthase RNAi reduces total naringenin precursor pool available for glycosylation
  • CHI chalcone isomerase modification channels chalcone flux away from naringenin accumulation

Key Interventions

RhaT rhamnosyltransferase RNAiGT1 isoform redirectionCHS chalcone suppression

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
60
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III Citrus sinensis lines with validated naringin reduction for fresh juice processing, citrus-flavored beverages, and functional food applications where grapefruit-like bitterness would otherwise activate TAS2R38 to objectionable levels.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Zero-Bitter · IFI-BAll Modalities